Hiroaki Kitano
Angel Investor
Hiroaki Kitano is a seed investor focused on Medical and Health Care. Senior Executive Vice President and CTO at Sony Group Corporation and President & CEO at Sony Computer Science Laboratories, Inc.. He attended Waseda University.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Hiroaki Kitano invests in
Stages Hiroaki Kitano invests in
Countries Hiroaki Kitano invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $2.7M–$7.1M
Investment Focus
Industry
- Medical 4 (50%)
- Health Care 4 (50%)
- Fitness 3 (38%)
- Wellness 2 (25%)
- Biotechnology 2 (25%)
Stage
- Seed 3 (38%)
- Angel 3 (38%)
- Funding Round 1 (13%)
- Debt Financing 1 (13%)
Country
- Japan 5 (63%)
- United States 2 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| AnotherBall is a blockchain startup that combines entertainment and blockchain. | $2.2M / Angel / May 16, 2023 | ||
| GPx is a biotech company that revolutionizes remote chronic disease management with bloodless blood tests. It is dedicated to transforming the standard of care of cardiorenal diseases and enabling patients to better understand their condition, much like the continuous glucose monitor has transformed diabetes care.The company was founded in 2020and is based in Boston, Massachusetts. | $3.3M / Seed / Sep 30, 2022 | ||
| Epistra accelerates research and development in life sciences. | Angel / Oct 30, 2019 | ||
| Activaid owns and operates a social data platform for patients with inflammatory bowel disease. It allows patients to support and exchange information within the patient community with the same disease; provide information necessary for new drug development and matching to clinical trials that suits them; and improve medical treatment. YasuakiHasebe founded Activaid in 2018. It has its headquarters in Tokyo in Japan. | Angel / Jun 13, 2019 | ||
| Integriculture makes cellular agriculture products to improve sustainability, food security, and reduce public health problems. The company offers a developed patented general-purpose large-scale cell culture system that can culture wide range of cells without external addition of expensive growth factors and provide consumers with affordable cleanmeat.Founded in 2015, Integriculture is headquartered in Tokyo, Japan. | $2.7M / Seed / May 25, 2018 | ||
| Genomelink is a platform where people discover more with their DNA data and help businesses build, market and do research with it. The best founders in consumer genomics with real experience in the industry for many years, including M3, Inc. ($13B valued Meditech in Japan), a founding member of the Japanese version of 23andMe, and leadbioinformatician and software engineer at a joint-venture between Illumina and Sony. Raised $4M for Seed Round from Berkeley SkyDeck, SONY, and top-tier Japanese VCs. Supported by Illumina Accelerator, Carlos Bustamante Lab at Stanford University among others. | $7.1M / Seed / Aug 22, 2017 | ||
| FiNC Technologies is a health tech company specializing in AI-driven wellness solutions. Their platform combines data analysis, rich content, and social elements to assist users in logging, understanding, managing, and improving their health and wellness. It empowers individuals to achieve their health goals effectively by leveraging machinelearning and personalized coaching. | $5.3M / Debt Financing / Aug 24, 2015 | ||
| SBX Corporation specializes in leveraging artificial intelligence to drive major scientific discoveries aimed at improving the global state. With a focus on computer science, biology, and their applications in drug discovery and biomedicine, SBX employs a dynamic team of scientists and engineers. The company's mission is to create an engine ofscientific discovery, utilizing AI to push the boundaries of what is possible in science and technology. Through research collaboration projects and the development of innovative AI systems, SBX aims to contribute significantly to the scientific community and the betterment of the world. |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Hiroaki Kitano invest in?
Hiroaki Kitano invests primarily in Medical, Health Care and Fitness startups, most often at Seed and Angel stage. Most of the 8 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Hiroaki Kitano invest in?
Hiroaki Kitano typically joins rounds of $2.7M–$7.1M at Seed. These are whole funding-round sizes, not Hiroaki Kitano's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Hiroaki Kitano took part in.
How do I contact Hiroaki Kitano?
Public channels for Hiroaki Kitano include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Hiroaki Kitano last invest?
The most recent investment recorded for Hiroaki Kitano closed in May 2023. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
